Selective tumor antigen vaccine delivery to human CD169


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 11 2020
Historique:
pubmed: 18 10 2020
medline: 8 1 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

Priming of CD8

Identifiants

pubmed: 33067394
pii: 2006186117
doi: 10.1073/pnas.2006186117
pmc: PMC7959579
doi:

Substances chimiques

Antigens, Neoplasm 0
Cancer Vaccines 0
Gangliosides 0
Liposomes 0
Proto-Oncogene Proteins 0
SIGLEC1 protein, human 0
Sialic Acid Binding Ig-like Lectin 1 0
Vaccines, Subunit 0
Receptor Protein-Tyrosine Kinases EC 2.7.10.1
Axl Receptor Tyrosine Kinase 0
AXL protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27528-27539

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Sci Transl Med. 2014 Apr 16;6(232):232ra51
pubmed: 24739759
Sci Immunol. 2017 Jul 7;2(13):
pubmed: 28783704
Front Immunol. 2019 Feb 28;10:347
pubmed: 30891035
J Control Release. 2012 May 30;160(1):88-95
pubmed: 22366522
Cancer Sci. 2013 Sep;104(9):1237-44
pubmed: 23734742
Nat Microbiol. 2019 Sep;4(9):1558-1570
pubmed: 31160823
ACS Nano. 2018 Oct 23;12(10):9815-9829
pubmed: 30256609
Elife. 2016 Aug 03;5:
pubmed: 27487469
Nat Rev Immunol. 2014 Oct;14(10):653-66
pubmed: 25234143
J Biol Chem. 1997 Jul 4;272(27):16889-95
pubmed: 9201997
J Immunol. 2003 Feb 15;170(4):2186-94
pubmed: 12574392
Science. 2017 Jun 9;356(6342):
pubmed: 28473638
Front Immunol. 2018 Sep 06;9:1997
pubmed: 30237798
Nat Rev Clin Oncol. 2020 Feb;17(2):108-123
pubmed: 31705130
Immunol Cell Biol. 2016 May;94(5):430-8
pubmed: 26647968
Nat Commun. 2014 Jun 20;5:4136
pubmed: 24947940
Chem Rev. 2015 Oct 14;115(19):10938-66
pubmed: 26010257
JCI Insight. 2016 May 19;1(7):e87102
pubmed: 27699265
EMBO J. 1991 Jul;10(7):1661-9
pubmed: 2050106
Cancer Immunol Res. 2015 Dec;3(12):1356-63
pubmed: 26297710
Blood Adv. 2018 Apr 24;2(8):941-953
pubmed: 29692344
Nature. 2017 Feb 23;542(7642):445-449
pubmed: 28199305
Front Immunol. 2018 Oct 26;9:2472
pubmed: 30416504
Immunology. 2008 Mar;123(3):438-46
pubmed: 17944899
Immunology. 1997 Oct;92(2):307-16
pubmed: 9415041
J Control Release. 2015 Oct 28;216:37-46
pubmed: 26151293
PLoS One. 2008 Apr 16;3(4):e1967
pubmed: 18414664
J Pharmacol Exp Ther. 2000 Mar;292(3):1071-9
pubmed: 10688625
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Nature. 2017 Nov 23;551(7681):512-516
pubmed: 29132146
Lancet Oncol. 2014 Jun;15(7):e257-67
pubmed: 24872109
J Am Chem Soc. 2012 Sep 26;134(38):15696-9
pubmed: 22967315
Cancers (Basel). 2019 Feb 05;11(2):
pubmed: 30764534
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7826-31
pubmed: 23610394
Ann Oncol. 2000 Aug;11(8):965-70
pubmed: 11038032
Cancer Immunol Res. 2019 Jun;7(6):886-895
pubmed: 31043417
Nature. 2020 Jan;577(7788):95-102
pubmed: 31894150
Clin Cancer Res. 2016 Apr 15;22(8):1897-906
pubmed: 27084743
J Biochem. 1998 Mar;123(3):468-78
pubmed: 9538230
Blood. 2007 Mar 15;109(6):2331-8
pubmed: 17082316
Curr Oncol Rep. 2019 May 17;21(7):60
pubmed: 31101991
Nat Rev Drug Discov. 2014 Sep;13(9):655-72
pubmed: 25103255
Immunity. 2017 Dec 19;47(6):1037-1050.e6
pubmed: 29221729
Cell. 2000 Mar 3;100(5):587-97
pubmed: 10721995
J Leukoc Biol. 2017 Oct;102(4):1017-1034
pubmed: 28729358
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9041-E9050
pubmed: 30190430
PLoS Pathog. 2013;9(4):e1003291
pubmed: 23593001
J Pharmacol Exp Ther. 2001 Aug;298(2):607-12
pubmed: 11454922
Vaccine. 2016 Jun 14;34(28):3229-34
pubmed: 27160038
JAMA Netw Open. 2019 May 3;2(5):e192535
pubmed: 31050774
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):216-21
pubmed: 20018690
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21685-21693
pubmed: 31591213
PLoS Biol. 2012;10(12):e1001448
pubmed: 23271952
Semin Immunopathol. 2012 May;34(3):353-64
pubmed: 22450957
Cancer Cell. 2018 Apr 9;33(4):563-569
pubmed: 29634944
PLoS One. 2012;7(6):e39039
pubmed: 22723922
Front Immunol. 2018 Dec 03;9:2804
pubmed: 30559743
Viruses. 2019 Dec 19;12(1):
pubmed: 31861617
N Engl J Med. 2017 Dec 21;377(25):2500-2501
pubmed: 29262275
Cell Rep. 2019 Dec 10;29(11):3736-3750.e8
pubmed: 31825848
Cancer Sci. 2018 May;109(5):1723-1730
pubmed: 29520898
J Control Release. 2015 Apr 10;203:67-76
pubmed: 25656175
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5461-6
pubmed: 25922518
Nat Immunol. 2018 Jan;19(1):63-75
pubmed: 29203862
Science. 2015 Oct 30;350(6260):563-567
pubmed: 26429886
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7475-80
pubmed: 22529395
Cancer Gene Ther. 2006 Nov;13(11):1033-44
pubmed: 16841080
Front Immunol. 2018 May 07;9:990
pubmed: 29867967
Br J Cancer. 2013 Mar 5;108(4):914-23
pubmed: 23385730
Sci Technol Adv Mater. 2019 Jun 26;20(1):710-724
pubmed: 31275462
Theranostics. 2019 Aug 12;9(20):5797-5809
pubmed: 31534520
Blood. 2011 Oct 13;118(15):4111-9
pubmed: 21860028
Immunity. 2016 Sep 20;45(3):669-684
pubmed: 27637149
J Biol Chem. 2015 Nov 6;290(45):27345-27359
pubmed: 26370074
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
J Virol. 2014 Aug;88(16):8813-25
pubmed: 24872578
Cell Rep. 2018 Feb 6;22(6):1484-1495
pubmed: 29425504
Science. 2016 Apr 8;352(6282):242-6
pubmed: 26989197
Arthritis Rheum. 2007 Mar;56(3):1010-20
pubmed: 17328080
Cell Host Microbe. 2019 Jan 9;25(1):87-100.e10
pubmed: 30595553
Front Immunol. 2018 Jun 14;9:1231
pubmed: 29963041
Front Immunol. 2018 Dec 07;9:2807
pubmed: 30581432

Auteurs

Alsya J Affandi (AJ)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Joanna Grabowska (J)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Katarzyna Olesek (K)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Miguel Lopez Venegas (M)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
DC4U, 3621 ZA Breukelen, The Netherlands.

Arnaud Barbaria (A)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Ernesto Rodríguez (E)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Patrick P G Mulder (PPG)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Helen J Pijffers (HJ)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Martino Ambrosini (M)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Hakan Kalay (H)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Tom O'Toole (T)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Eline S Zwart (ES)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Geert Kazemier (G)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Kamran Nazmi (K)

Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam and University of Amsterdam, 1081 LA Amsterdam, The Netherlands.

Floris J Bikker (FJ)

Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam and University of Amsterdam, 1081 LA Amsterdam, The Netherlands.

Johannes Stöckl (J)

Institute of Immunology, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.

Alfons J M van den Eertwegh (AJM)

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Tanja D de Gruijl (TD)

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Gert Storm (G)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, The Netherlands.
Department of Biomaterials, Science and Technology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.

Yvette van Kooyk (Y)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
DC4U, 3621 ZA Breukelen, The Netherlands.

Joke M M den Haan (JMM)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands; j.denhaan@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH